BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7782092)

  • 1. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
    Walker TM; Burger CJ; Elgert KD
    Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
    Alleva DG; Burger CJ; Elgert KD
    Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
    Alleva DG; Burger CJ; Elgert KD
    Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced variations in a high molecular weight inhibitory monokine.
    Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
    Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
    Walker TM; Burger CJ; Elgert KD
    Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    Alleva DG; Walker TM; Elgert KD
    J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
    Walker TM; Burger CJ; Elgert KD
    Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
    Askew D; Burger CJ; Elgert KD
    Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
    Askew D; Burger CJ; Elgert KD
    Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.
    Yurochko AD; Nagarkatti PS; Nagarkatti M; Elgert KD
    Cancer Immunol Immunother; 1989; 30(3):170-6. PubMed ID: 2598186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of ICAM-1 on macrophages stimulated with Mycobacterium avium complex and its control by some regulatory cytokines].
    Maw WW; Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Oct; 71(10):561-7. PubMed ID: 8936990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.